Development of a screening score for undiagnosed diabetes and its application in estimating absolute risk of future type 2 diabetes in Japan: Toranomon Hospital Health Management Center Study 10 (TOPICS 10).

OBJECTIVE The objective of the study was to develop a screening score for undiagnosed diabetes by eliciting information on noninvasive clinical markers and to assess its effectiveness for identifying the presence of diabetes and predicting future diabetes. DESIGN, SETTING, AND PARTICIPANTS A screening score was cross-sectionally developed for 33 335 Japanese individuals aged 18-88 years without known diabetes who underwent a health examination. We validated its utility and compared it with existing screening tools in an independent population (n = 7477). After initial assessment of the instrument, 7332 nondiabetic individuals were followed up for a mean 4.0 years. RESULTS Prevalence of undiagnosed diabetes (fasting plasma glucose ≥ 7.0 mmol/L or glycated hemoglobin ≥ 6.5%) was 2.9% (n = 965). Diabetes score included age, sex, family history of diabetes, current smoking habit, body mass index, and hypertension with an area under the receiver-operating characteristics curve of 0.771. Screening with 8 or more points yielded a sensitivity of 72.7% and a specificity of 68.1%. In the validation cohort, the area under the receiver-operating characteristics curve was 0.806. The developed score with 8 or more points had better positive predictive value (9.6%) and positive likelihood ratio (2.52) compared with existing tools (positive predictive value, from 6.9% to 9.4%; positive likelihood ratio, from 1.77 to 2.46) in which each tool's highest combination of sensitivity and specificity was observed. The 4-year cumulative risk of developing diabetes gradually escalated in association with higher screening scores at the initial examination. CONCLUSIONS Our algorithm could serve as a self-assessment tool for undiagnosed diabetic patients needing timely medical care and as a prognostic tool for individuals without present diabetes who must be closely followed up to prevent future diabetes.

[1]  Y. Ohashi,et al.  Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6) , 2012, Diabetologia.

[2]  H. Bang,et al.  A Simple Screening Score for Diabetes for the Korean Population , 2012, Diabetes Care.

[3]  J. Lindström,et al.  Nonpharmacological interventions for the prevention of type 2 diabetes mellitus , 2012, Nature Reviews Endocrinology.

[4]  L. Thorpe,et al.  Understanding and Addressing Unique Needs of Diabetes in Asian Americans, Native Hawaiians, and Pacific Islanders , 2012, Diabetes Care.

[5]  K. Fujihara,et al.  Longitudinal Trajectories of HbA1c and Fasting Plasma Glucose Levels During the Development of Type 2 Diabetes , 2012, Diabetes Care.

[6]  Rui Li,et al.  Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention: a cost-effectiveness perspective. , 2012, American journal of preventive medicine.

[7]  P. Zimmet,et al.  The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives , 2012, Nature Reviews Endocrinology.

[8]  T. Sanke,et al.  International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values , 2012, Diabetology International.

[9]  K. Khunti,et al.  Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting , 2012, Diabetologia.

[10]  K. Khunti,et al.  Screening for Type 2 diabetes. Lessons from the ADDITION‐Europe study , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[11]  G. Collins,et al.  Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting , 2011, BMC medicine.

[12]  T. Tankova,et al.  Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. , 2011, Diabetes research and clinical practice.

[13]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[14]  R. Simmons,et al.  Screening for type 2 diabetes: an update of the evidence , 2010, Diabetes, obesity & metabolism.

[15]  K. Khunti,et al.  The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[16]  A. Stadlmayr,et al.  A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[17]  A. Rissanen,et al.  Take Action to Prevent Diabetes – The IMAGE Toolkit for the Prevention of Type 2 Diabetes in Europe , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  M. Marmot,et al.  Performance of existing risk scores in screening for undiagnosed diabetes: an external validation study , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[19]  L. Zhang,et al.  A simple Chinese risk score for undiagnosed diabetes , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[20]  S. Liatis,et al.  Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE‐PLAN study , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[21]  Heejung Bang,et al.  Development and Validation of a Patient Self-assessment Score for Diabetes Risk , 2009, Annals of Internal Medicine.

[22]  P. Schwarz,et al.  Prevention of Diabetes Self-Management Program (PREDIAS): Effects on Weight, Metabolic Risk Factors, and Behavioral Outcomes , 2009, Diabetes Care.

[23]  Mika Kivimäki,et al.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study , 2009, The Lancet.

[24]  Nicholas J Wareham,et al.  A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study. , 2008, Family practice.

[25]  David M. Eddy,et al.  Diabetes Risk Calculator , 2008, Diabetes Care.

[26]  R. Stolk,et al.  Low yield of population-based screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study. , 2007, Family practice.

[27]  J Tuomilehto,et al.  Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East. , 2007, Diabetes research and clinical practice.

[28]  Nicola J Cooper,et al.  Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[29]  N. Wareham,et al.  Derivation and validation of diabetes risk score for urban Asian Indians. , 2005, Diabetes research and clinical practice.

[30]  Gianni Tognoni,et al.  Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. , 2005, Diabetes care.

[31]  R. Holle,et al.  Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000. , 2005, Archives of internal medicine.

[32]  K. Borch-Johnsen,et al.  Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms , 2004, Diabetologia.

[33]  Bendix Carstensen,et al.  A Danish diabetes risk score for targeted screening: the Inter99 study. , 2004, Diabetes care.

[34]  Jaakko Tuomilehto,et al.  The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.

[35]  N. Wareham,et al.  Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice , 2000, Diabetes/metabolism research and reviews.

[36]  E. Feskens,et al.  Performance of a predictive model to identify undiagnosed diabetes in a health care setting. , 1999, Diabetes care.

[37]  L. Bouter,et al.  Performance of an NIDDM Screening Questionnaire Based on Symptoms and Risk Factors , 1997, Diabetes Care.

[38]  M. Engelgau,et al.  A New and Simple Questionnaire to Identify People at Increased Risk for Undiagnosed Diabetes , 1995, Diabetes Care.